Buscar
Mostrando ítems 21-30 de 85
Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA)
(Bmj Publishing Group, 2016)
Objectives To evaluate the long-term efficacy and safety of subcutaneous (SC) tocilizumab (TCZ) versus intravenous (IV) TCZ, including switching formulations, in patients with rheumatoid arthritis (RA) and inadequate ...
Infecções graves em pacientes com artrite reumatoide expostos aos medicamentos biológicos: relevância e modificações da taxa com o tempo – dados de registros da américa do sulThe changing rate of serious infections in biologic-exposed rheumatoid arthritis patients: Data from South American registries
(Universidade Federal de UberlândiaBrasilPrograma de Pós-graduação em Ciências da Saúde, 2019)
Consenso 2012 da Sociedade Brasileira de Reumatologia para o tratamento da artrite reumatoide2012 Brazilian Society of Rheumatology Consensus for the treatment of rheumatoid arthritis
(Sociedade Brasileira de ReumatologiaBrasil, 2012)
Eficácia, uso de medicamentos e gastos no tratamento da artrite reumatoide no sistema único de saúde, 2003 a 2006
(Universidade Federal de Minas GeraisUFMG, 2012-12-21)
Rheumatoid arthritis (RA) is a chronic autoimmune incapacitating disease, which leads to loss of quality of life and causes economic impacts for patients and for society. Pharmacological treatment includes the use of ...
Predictors of Remission and Low Disease Activity in Rheumatoid Arthritis Patients: Results From the Follow-up of a Real-World Peruvian Cohort
(Wolters Kluwer Health, 2022)
Background Clinical remission is the goal in rheumatoid arthritis (RA) management; however, this can be difficult to achieve in several parts of the world. Our objective was to determine predictors of remission and ...
Update On The 2012 Brazilian Society Of Rheumatology Guidelines For The Treatment Of Rheumatoid Arthritis: Position On The Use Of Tofacitinib
(ELSEVIER SCIENCE INCNEW YORK, 2015)